Logo image of KRUS

KURA SUSHI USA INC-CLASS A (KRUS) Stock Fundamental Analysis

NASDAQ:KRUS - Nasdaq - US5012701026 - Common Stock - Currency: USD

61.09  +0.19 (+0.31%)

After market: 61.09 0 (0%)

Fundamental Rating

4

KRUS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 136 industry peers in the Hotels, Restaurants & Leisure industry. No worries on liquidiy or solvency for KRUS as it has an excellent financial health rating, but there are worries on the profitability. KRUS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

KRUS had negative earnings in the past year.
KRUS had a positive operating cash flow in the past year.
KRUS had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: KRUS reported negative operating cash flow in multiple years.
KRUS Yearly Net Income VS EBIT VS OCF VS FCFKRUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

KRUS has a Return On Assets of -2.56%. This is in the lower half of the industry: KRUS underperforms 71.32% of its industry peers.
KRUS has a Return On Equity (-4.67%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.56%
ROE -4.67%
ROIC N/A
ROA(3y)-0.86%
ROA(5y)-4.62%
ROE(3y)-1.79%
ROE(5y)-10.96%
ROIC(3y)N/A
ROIC(5y)N/A
KRUS Yearly ROA, ROE, ROICKRUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

KRUS has a worse Gross Margin (19.24%) than 85.29% of its industry peers.
In the last couple of years the Gross Margin of KRUS has declined.
KRUS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.07%
GM growth 5Y-1.7%
KRUS Yearly Profit, Operating, Gross MarginsKRUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

8

2. Health

2.1 Basic Checks

KRUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for KRUS has been increased compared to 1 year ago.
KRUS has more shares outstanding than it did 5 years ago.
KRUS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
KRUS Yearly Shares OutstandingKRUS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
KRUS Yearly Total Debt VS Total AssetsKRUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 2.97 indicates that KRUS is not a great score, but indicates only limited risk for bankruptcy at the moment.
KRUS's Altman-Z score of 2.97 is fine compared to the rest of the industry. KRUS outperforms 78.68% of its industry peers.
KRUS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.97
ROIC/WACCN/A
WACC9%
KRUS Yearly LT Debt VS Equity VS FCFKRUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 2.67 indicates that KRUS has no problem at all paying its short term obligations.
The Current ratio of KRUS (2.67) is better than 91.91% of its industry peers.
KRUS has a Quick Ratio of 2.60. This indicates that KRUS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.60, KRUS belongs to the top of the industry, outperforming 91.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.67
Quick Ratio 2.6
KRUS Yearly Current Assets VS Current LiabilitesKRUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

6

3. Growth

3.1 Past

KRUS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -585.71%.
The Revenue has grown by 21.37% in the past year. This is a very strong growth!
KRUS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.94% yearly.
EPS 1Y (TTM)-585.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.56%
Revenue 1Y (TTM)21.37%
Revenue growth 3Y54.18%
Revenue growth 5Y29.94%
Sales Q2Q%13.27%

3.2 Future

Based on estimates for the next years, KRUS will show a very strong growth in Earnings Per Share. The EPS will grow by 21.07% on average per year.
The Revenue is expected to grow by 18.41% on average over the next years. This is quite good.
EPS Next Y98.6%
EPS Next 2Y55.09%
EPS Next 3Y35.5%
EPS Next 5Y21.07%
Revenue Next Year18.54%
Revenue Next 2Y19.71%
Revenue Next 3Y19.67%
Revenue Next 5Y18.41%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
KRUS Yearly Revenue VS EstimatesKRUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
KRUS Yearly EPS VS EstimatesKRUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 2 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KRUS. In the last year negative earnings were reported.
KRUS is valuated quite expensively with a Price/Forward Earnings ratio of 206.43.
KRUS's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. KRUS is more expensive than 68.38% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.42. KRUS is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 206.43
KRUS Price Earnings VS Forward Price EarningsKRUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 100 150 200

4.2 Price Multiples

85.29% of the companies in the same industry are cheaper than KRUS, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 430.44
KRUS Per share dataKRUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates KRUS does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as KRUS's earnings are expected to grow with 35.50% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.09%
EPS Next 3Y35.5%

More info and screens

0

5. Dividend

5.1 Amount

KRUS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KURA SUSHI USA INC-CLASS A

NASDAQ:KRUS (5/6/2025, 8:20:49 PM)

After market: 61.09 0 (0%)

61.09

+0.19 (+0.31%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)04-08 2025-04-08/amc
Earnings (Next)N/A N/A
Inst Owners77.87%
Inst Owner Change-1.64%
Ins Owners6.84%
Ins Owner Change1.1%
Market Cap738.58M
Analysts78.75
Price Target65.73 (7.6%)
Short Float %21.3%
Short Ratio3.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)28.17%
Min EPS beat(2)-5.58%
Max EPS beat(2)61.93%
EPS beat(4)1
Avg EPS beat(4)-6629.19%
Min EPS beat(4)-26473.1%
Max EPS beat(4)61.93%
EPS beat(8)3
Avg EPS beat(8)-3341.92%
EPS beat(12)6
Avg EPS beat(12)-2194.36%
EPS beat(16)10
Avg EPS beat(16)-1641.39%
Revenue beat(2)1
Avg Revenue beat(2)0.2%
Min Revenue beat(2)-1.99%
Max Revenue beat(2)2.38%
Revenue beat(4)2
Avg Revenue beat(4)-0.2%
Min Revenue beat(4)-1.99%
Max Revenue beat(4)2.38%
Revenue beat(8)2
Avg Revenue beat(8)-1.23%
Revenue beat(12)4
Avg Revenue beat(12)-0.56%
Revenue beat(16)7
Avg Revenue beat(16)1.21%
PT rev (1m)-40.63%
PT rev (3m)-43.03%
EPS NQ rev (1m)-22.57%
EPS NQ rev (3m)-17.49%
EPS NY rev (1m)-113.21%
EPS NY rev (3m)-146.15%
Revenue NQ rev (1m)-1.07%
Revenue NQ rev (3m)-0.44%
Revenue NY rev (1m)-0.52%
Revenue NY rev (3m)-0.63%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 206.43
P/S 2.86
P/FCF N/A
P/OCF 40.99
P/B 3.28
P/tB 3.28
EV/EBITDA 430.44
EPS(TTM)-0.68
EYN/A
EPS(NY)0.3
Fwd EY0.48%
FCF(TTM)-2.28
FCFYN/A
OCF(TTM)1.49
OCFY2.44%
SpS21.38
BVpS18.61
TBVpS18.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.56%
ROE -4.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.24%
FCFM N/A
ROA(3y)-0.86%
ROA(5y)-4.62%
ROE(3y)-1.79%
ROE(5y)-10.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.07%
GM growth 5Y-1.7%
F-Score4
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 350.42%
Cap/Sales 17.63%
Interest Coverage N/A
Cash Conversion 1186.89%
Profit Quality N/A
Current Ratio 2.67
Quick Ratio 2.6
Altman-Z 2.97
F-Score4
WACC9%
ROIC/WACCN/A
Cap/Depr(3y)464%
Cap/Depr(5y)432.88%
Cap/Sales(3y)20.03%
Cap/Sales(5y)22.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-585.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.56%
EPS Next Y98.6%
EPS Next 2Y55.09%
EPS Next 3Y35.5%
EPS Next 5Y21.07%
Revenue 1Y (TTM)21.37%
Revenue growth 3Y54.18%
Revenue growth 5Y29.94%
Sales Q2Q%13.27%
Revenue Next Year18.54%
Revenue Next 2Y19.71%
Revenue Next 3Y19.67%
Revenue Next 5Y18.41%
EBIT growth 1Y-1058.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year439.32%
EBIT Next 3Y103.65%
EBIT Next 5Y56.86%
FCF growth 1Y-92.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.12%
OCF growth 3YN/A
OCF growth 5Y21.12%